News Focus
News Focus
icon url

OFP

12/26/18 9:41 AM

#176149 RE: falconer66a #176146

“Cellular Homeostasis” Is Complex

AVXL has described cellular homeostasis as a general S1R agonist function. They have never given any credible reason to expect an advantage of 2-73 over other agonists.
icon url

Investor2014

12/26/18 9:45 AM

#176150 RE: falconer66a #176146

The sigma-1 receptor is a 223 amino acids molecular chaperone with a single transmembrane domain. It is resident to eukaryotic mitochondrial-associated endoplasmic reticulum and plasma membranes. By chaperone-mediated interactions with ion channels, G-protein coupled receptors and cell-signaling molecules, the sigma-1 receptor performs broad physiological and pharmacological functions. Despite sigma-1 receptors have been confirmed to regulate various types of ion channels, the relationship between the sigma-1 receptor and N-type Ca2+ channel is still unclear. Considering both sigma-1 receptors and N-type Ca2+ channels are involved in intracellular calcium homeostasis and neurotransmission, we undertake studies to explore the possible interaction between these two proteins. In the experiment, we confirmed the expression of the sigma-1 receptors and the N-type calcium channels in the cholinergic interneurons (ChIs) in rat striatum by using single-cell reverse transcription-polymerase chain reaction (scRT-PCR) and immunofluorescence staining. N-type Ca2+ currents recorded from ChIs in the brain slice of rat striatum was depressed when sigma-1 receptor agonists (SKF-10047 and Pre-084) were administrated. The inhibition was completely abolished by sigma-1 receptor antagonist (BD-1063). Co-expression of the sigma-1 receptors and the N-type calcium channels in Xenopus oocytes presented a decrease of N-type Ca2+ current amplitude with an increase of sigma-1 receptor expression. SKF-10047 could further depress N-type Ca2+ currents recorded from oocytes. The fluorescence resonance energy transfer (FRET) assays and co-immunoprecipitation (Co-IP) demonstrated that sigma-1 receptors and N-type Ca2+ channels formed a protein complex when they were co-expressed in HEK-293T (Human Embryonic Kidney -293T) cells. Our results revealed that the sigma-1 receptors played a negative modulation on N-type Ca2+ channels. The mechanism for the inhibition of sigma-1 receptors on N-type Ca2+ channels probably involved a chaperone-mediated direct interaction and agonist-induced conformational changes in the receptor-channel complexes on the cell surface.


Sigma-1 Receptor Plays a Negative Modulation on N-type Calcium Channel


Sigma-1 receptors are widely spread in the central nervous system, liver, kidneys, and lungs, in the endocrine, immune and reproductive tissues [9]. This receptor is a transmembrane protein specifically located in ceramide- and cholesterol-rich lipid microdomains associated with the mitochondria of the ER membrane. It regulates the function of the inositol-3-phosphate receptor, stabilizing calcium signaling between the ER and the mitochondrion. It has been shown that the sigma-1 receptor forms ??2+-regulating trimeric complex with ankyrin-B and the inositol-3-phosphate receptor in NG-108 neuroblastoma cells [10].



Sigma-1 receptor as a potential pharmacological target for the treatment of neuropathology

CONCLUSIONS:
These results suggest that sigma-1 receptor activation can regulate calcium homeostasis and signaling in RGCs, likely by directly influencing the activity of L-type voltage-gated calcium channels. Regulation of calcium influx in RGCs by sigma-1 receptor ligands may represent in part the neuroprotective effect of sigma-1 receptors.


Sigma-1 receptor regulation of voltage-gated calcium channels involves a direct interaction.

icon url

OFP

12/26/18 9:55 AM

#176154 RE: falconer66a #176146

What I described (regarding the BAG3 gene and its tau-clearing protein, and how Anavex 2-73 might facilitate its full function) touches upon the restoration of a neuron homeostasis. But, altogether, far more complex.

If one is to claim something particular to 2-73 over other S1R agonists one should be able to provide credible reasons as to why it is unique or advantageous.
icon url

Talon38

12/26/18 5:11 PM

#176257 RE: falconer66a #176146

Falconer....good explanation of the Alzheimer's (Dementia) mechanics and the the fix. Can we now connect the people involved with "malfunction analysis" like Columbia and the fixer like Anavex. Maybe the ACTC will do that.

-----

“If we can develop therapies to support these natural defense mechanisms and stop tau from accumulating, we might be able to prevent, or at least slow, the development of Alzheimer's and other tau-related neurodegenerative diseases,” said lead author Karen Duff, Ph.D., professor of pathology and cell biology at Columbia, in the statement.


icon url

powerwalker

12/27/18 9:22 AM

#176288 RE: falconer66a #176146

Thank you, again, falconer, for that comprehensive description (I was expecting a few sentences). I know it is not this simple, but it seems that the homeostasis by 2-73 is the water to the cell/neuron's plant.

We, or at least, most of us, so much appreciate you and your insight and knowledge that you provide this board.

Peace and Merry Christmas and Happy Holidays to one and all!

Anavex Now ... Mono-style ... and Life!!!